The study and its comparison
One hundred adults aged 50–85 with age-associated memory impairment were randomized to citicoline 500 mg daily or placebo; 99 completed the study. Spatial Span was the primary test. [1]
Paired Associates and a composite memory score improved versus placebo after adjustment for multiple comparisons. Spatial Span improved within the treated group, which is not the same as a significant advantage over placebo. [1]
What the finding establishes
The trial does not establish dementia prevention or a benefit from equal milligrams of choline bitartrate. Kyowa Hakko funded the study and helped design it; authors disclosed company and research-service employment. Specific test gains should remain separate from broad memory claims. [1]
A hypothetical distinction
Imagine the headline highlights two secondary tests. Check what happened to the prespecified primary comparison as well.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial - PMC
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.